Ocera Announces Successful Phase 1 Clinical Study of Orally-Administered OCR-002 in Patients with Cirrhosis Life Science Investing
Q BioMed Inc. to Present at Biotech Showcase 2017 in San Francisco Jan 9 – 11th Life Science Investing
OncoMed Initiates Enrollment of Phase 1b Clinical Trial for Metastatic Colorectal Cancer Patients Life Science Investing
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Life Science Investing
Protalix BioTherapeutics Announces Positive Interim Results from Phase II Clinical Trial of AIR DNase™ for the Treatment of Cystic Fibrosis Life Science Investing
TRACON Pharmaceuticals Receives Special Protocol Assessment Agreement from FDA Pharmaceutical Investing
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL® (bupivacaine HCl collagen-matrix implants) New Drug Application Life Science Investing
Strongbridge Biopharma Announces Closing of $35 Million Equity Financing and $40 Million Credit Facility Pharmaceutical Investing
